Atlas FDA

Liquid Urine Control Level 3 For Professional Use in the quality control monitoring of In-Vitro Diagnostic Urinary Clini

FDA device recall Z-2167-2017 · posted 2017-05-26 · Terminated

Recall details

Recalling firm
Randox Laboratories
Reason for recall
According to Randox Laboratories an investigation indicates a labelling error for 2 of the test methods listed for quantification of Total Protein (urine). The values for the mean of all instruments are incorrect by a factor of 10. Instrument specific values are correct. This does not affect the performance or stability claims of the product. As control results will be outside of the quoted range this may result in a delay in reporting the sample test results. However as the correct instrument specific means are also included in the value sheet this delay is unlikely. Customers have been referred to their Medical Director for further advice
Action taken
Randox Laboratories will contact Customers directly by e-mail and will be followed up with once every 2 weeks over a period of 6 weeks. There are no plans in place to follow up with customers after the 6 week period. For further questions, please call (304) 728-2890.
Root cause
Error in labeling
Status
Terminated
Product code
JJY
Quantity affected
198 kits
Distribution
Worldwide Distribution - US Distribution to Puerto Rico and to the countries of : Canada Kuwait Chile Poland China Romania France Saudi Arabia Guatemala Slovenia Iran UAE India UK Italy Uruguay Iraq
Date initiated
2017-04-27
Date posted
2017-05-26
Date terminated
2017-08-14
Location
Kearneysville, WV

Monitor recalls programmatically

Recalls and clearances share one API, with change alerts when new recalls post.

Related 510(k) clearances

RecordFirmDate
RANDOX LIQUID URINE CONTROL LEVELS 2 AND 3 (K110904)Randox Laboratories, Ltd.2011-09-30